2000
DOI: 10.1007/pl00000705
|View full text |Cite
|
Sign up to set email alerts
|

Dysfunctional insulin secretion in type 2 diabetes: role of metabolic abnormalities

Abstract: Insulin secretion is finely tuned to the requirements of tissues by tight coupling to prevailing blood glucose levels. The normal regulation of insulin secretion is coupled to glucose metabolism in the pancreatic B cell, a major but not exclusive signal for secretion being closure of K+ ATP (adenosine' triphosphate)-dependent channels in the cell membrane through an increase in cytosolic ATP/adenosine diphosphate. Insulin secretion in type 2 diabetes is abnormal in several respects due to genetic causes but al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
28
0

Year Published

2001
2001
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(30 citation statements)
references
References 104 publications
2
28
0
Order By: Relevance
“…A diminished insulin response to acute glucose stimulation (glucose desensitization) has been reported to characterize islets subjected to chronic hyperglycemia in vitro (34 -36) and in vivo (16,(37)(38)(39)(40)(41). In contrast, an increased glucose sensitivity characterized islets from 90% pancreatectomized rats (42), dexamethasone-treated (43) and 48-h glucose-infused rats (44), and normal rat islets cultured for several days in the presence of high glucose concentrations (45)(46)(47). However, the occurrence of maximal stimulation of insulin secretion at low physiological glucose concentration, as observed in DP-HE islets and in other models of chronic hyperglycemia (48), could be easily misinterpreted as a lack of glucose-induced insulin secretion if only tested between 4 and 10 -20 mmol/l glucose (42,46).…”
Section: Discussionmentioning
confidence: 99%
“…A diminished insulin response to acute glucose stimulation (glucose desensitization) has been reported to characterize islets subjected to chronic hyperglycemia in vitro (34 -36) and in vivo (16,(37)(38)(39)(40)(41). In contrast, an increased glucose sensitivity characterized islets from 90% pancreatectomized rats (42), dexamethasone-treated (43) and 48-h glucose-infused rats (44), and normal rat islets cultured for several days in the presence of high glucose concentrations (45)(46)(47). However, the occurrence of maximal stimulation of insulin secretion at low physiological glucose concentration, as observed in DP-HE islets and in other models of chronic hyperglycemia (48), could be easily misinterpreted as a lack of glucose-induced insulin secretion if only tested between 4 and 10 -20 mmol/l glucose (42,46).…”
Section: Discussionmentioning
confidence: 99%
“…These areas were explored first because of their proposed roles as "feeding" and "satiety" centers respectively, making it logical that they might monitor peripheral glucose levels as a means of controlling ingestion (Grill and Bjorklund 2000). Since postprandial hyperglycemia has been recognized as an important risk factor for cardiovascular diseases, even among general healthy population (Coutinho et al 1999), it becomes necessary to manage glucose homeostasis by diet and its constituents.…”
Section: Plasma Hormonesmentioning
confidence: 99%
“…Dysregulation of any of these aspects of the nutrient response and/or alterations in ␤-cell differentiation and survival are potentially implicated in the onset of type 2 diabetes. This disease is associated with peripheral insulin resistance but only develops in conjunction with a failure of ␤-cell compensation, which otherwise counteracts the insulin resistance (2)(3)(4)(5). Type 2 diabetic patients display reductions in ␤-cell mass as compared with insulin-resistant nondiabetic individuals, as well as a number of clearly defined secretory abnormalities.…”
mentioning
confidence: 99%
“…Although ongoing hyperglycemia is undoubtedly a major contributor to ␤-cell decompensation, it is apparent that chronic elevations in circulating fatty acids (FAs) also accompany the progression to type 2 diabetes (3)(4)(5). Since FAs themselves stimulate insulin secretion, a key role in secretory compensation has been ascribed to their elevation (4,6).…”
mentioning
confidence: 99%